CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 60 filers reported holding CYTOSORBENTS CORP in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,266 | -47.6% | 3,333 | 0.0% | 0.00% | -33.3% |
Q2 2023 | $11,965 | +6.5% | 3,333 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $11,232 | +117.4% | 3,333 | 0.0% | 0.00% | +50.0% |
Q4 2022 | $5,166 | +3.3% | 3,333 | 0.0% | 0.00% | +100.0% |
Q3 2022 | $5,000 | -28.6% | 3,333 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $7,000 | -36.4% | 3,333 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $11,000 | -21.4% | 3,333 | 0.0% | 0.00% | -25.0% |
Q4 2021 | $14,000 | -48.1% | 3,333 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $27,000 | +8.0% | 3,333 | 0.0% | 0.01% | +14.3% |
Q2 2021 | $25,000 | -10.7% | 3,333 | 0.0% | 0.01% | -12.5% |
Q1 2021 | $28,000 | +7.7% | 3,333 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $26,000 | 0.0% | 3,333 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $26,000 | – | 3,333 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 450,000 | $846,000 | 0.90% |
Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |